Federal and Regulatory Outreach
AMRPA Comment Letter to USNWR re: 2024-25 Rankings Methodology
December 6, 2023
Rehab Rankings
AMRPA Sign-On Letter to Request Sub-Regulatory Guidance on CY2024 MA Rule
December 6, 2023
Medicare Advantage Prior Authorization Regulatory
AMRPA Comments on MedPAC October 2023 Session on IRF & SNF Payment Reform Models
October 25, 2023
MedPAC Unified PAC Payment
AMRPA Letter to CMS re: Certification Delays
October 5, 2023
Regulatory
AMRPA Comments on Senate HELP Committee on AI in Healthcare
September 22, 2023
Legislative Medicare Advantage Prior Authorization
AMRPA Comments on CY 2024 Hospital Outpatient Prospective Payment Systems Proposed Rule
September 12, 2023
Outpatient PPS Price Transparency Regulatory
AMRPA Comments on CY 2024 Medicare Physician Fee Schedule
September 12, 2023
Physician Fee Schedule Regulatory Telehealth
AMRPA Letter to CMS RE: IRF QRP Non-Compliance Determinations and Reconsideration Requests
September 6, 2023
IRF QRP
AMRPA-Led Stakeholder Letter to CMS re: Time-Sensitive Review Choice Demonstration Concerns & Delay Request
August 11, 2023
Regulatory Review Choice Demonstration
AMRPA Submits Comments for IRF Review Choice Demonstration
June 23, 2023
Regulatory Review Choice Demonstration
AMRPA Submits Comments for Congressional Hearing on MA Denials and Delays
June 2, 2023
Legislative Medicare Advantage Prior Authorization
AMRPA Comments on MedPAC’s IRF Recommendation for FY 2025